JP2015500873A5 - - Google Patents

Download PDF

Info

Publication number
JP2015500873A5
JP2015500873A5 JP2014548735A JP2014548735A JP2015500873A5 JP 2015500873 A5 JP2015500873 A5 JP 2015500873A5 JP 2014548735 A JP2014548735 A JP 2014548735A JP 2014548735 A JP2014548735 A JP 2014548735A JP 2015500873 A5 JP2015500873 A5 JP 2015500873A5
Authority
JP
Japan
Prior art keywords
imaging agent
imaging
isotope
kit
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014548735A
Other languages
English (en)
Japanese (ja)
Other versions
JP6140187B2 (ja
JP2015500873A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2012/051421 external-priority patent/WO2013095273A1/en
Publication of JP2015500873A publication Critical patent/JP2015500873A/ja
Publication of JP2015500873A5 publication Critical patent/JP2015500873A5/ja
Application granted granted Critical
Publication of JP6140187B2 publication Critical patent/JP6140187B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014548735A 2011-12-22 2012-12-18 心筋灌流イマジニング用造影剤 Expired - Fee Related JP6140187B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161579113P 2011-12-22 2011-12-22
SE1151249 2011-12-22
SE1151249-8 2011-12-22
US61/579,113 2011-12-22
PCT/SE2012/051421 WO2013095273A1 (en) 2011-12-22 2012-12-18 Contrast agent for imagining myocardial perfusion

Publications (3)

Publication Number Publication Date
JP2015500873A JP2015500873A (ja) 2015-01-08
JP2015500873A5 true JP2015500873A5 (enExample) 2016-02-12
JP6140187B2 JP6140187B2 (ja) 2017-05-31

Family

ID=48668967

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014548735A Expired - Fee Related JP6140187B2 (ja) 2011-12-22 2012-12-18 心筋灌流イマジニング用造影剤

Country Status (15)

Country Link
US (2) US9295738B2 (enExample)
EP (1) EP2793952B1 (enExample)
JP (1) JP6140187B2 (enExample)
KR (1) KR101931792B1 (enExample)
CN (1) CN104114191A (enExample)
AU (1) AU2012354223B2 (enExample)
BR (1) BR112014015124A2 (enExample)
CA (1) CA2859773C (enExample)
ES (1) ES2687234T3 (enExample)
IL (1) IL233219A (enExample)
MX (1) MX356258B (enExample)
RU (1) RU2629840C2 (enExample)
SG (1) SG11201403429YA (enExample)
WO (1) WO2013095273A1 (enExample)
ZA (1) ZA201405199B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9955876B2 (en) * 2016-09-08 2018-05-01 Raul Chirife Device and method for assessment of left ventricular ejection fraction and other parameters of cardiac performance
CN107233585B (zh) * 2017-06-09 2021-01-22 四川大学华西医院 黄连素或其衍生物在制备心肌灌注显像剂中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344702B2 (en) * 2004-02-13 2008-03-18 Bristol-Myers Squibb Pharma Company Contrast agents for myocardial perfusion imaging
US7932272B2 (en) * 2003-09-30 2011-04-26 Eisai R&D Management Co., Ltd. Antifungal agent containing heterocyclic compound
US7824659B2 (en) * 2005-08-10 2010-11-02 Lantheus Medical Imaging, Inc. Methods of making radiolabeled tracers and precursors thereof
US8415333B2 (en) 2009-02-24 2013-04-09 Respiratorious Ab Bronchodilating diazaheteroaryls

Similar Documents

Publication Publication Date Title
AR121016A2 (es) Sales de fenotiazindiaminio y su uso
JP2013014622A5 (enExample)
CL2015000578A1 (es) Compuesto n-(2-(6-fluoro-1-h-indol-3-il)etil)-3-(2,2,3,3-tetrafluoropropoxi)bencilamina o su sal, antagonista del receptor 5-ht6; composicion farmaceutica; uso en el tratamiento de la enfermedad de alzheimer.
JP2015522045A5 (enExample)
JP2016506935A5 (enExample)
JP2011105738A5 (enExample)
CY1123365T1 (el) Ενωσεις που εχουν δραστικοτητα ανταγωνιστη μουσκαρινικου υποδοχεα και αγωνιστη βητα2 αδρενεργικου υποδοχεα
JP2015024998A5 (enExample)
MX376163B (es) Compuestos heterocíclicos deuterados y su uso como agentes formadores de imágenes.
MY187047A (en) Selective pyy compounds and uses thereof
AR083879A1 (es) Analogos de aminoglicosidos antibacterianos, metodos de preparacion y uso como agentes terapeuticos
HRP20090077B1 (hr) Modulatori farmakokinetičkih svojstava terapeutika
EP3542790C0 (en) COMPOSITIONS CONTAINING A DELIVERY AGENT AND PRODUCTION THEREOF
JP2017514910A5 (enExample)
JP2017501236A5 (enExample)
WO2015021396A3 (en) Tricyclic benzoxaborole compounds and uses thereof
JP2019516739A5 (enExample)
JP2016506386A5 (enExample)
EA201401082A1 (ru) Фармацевтические препараты, содержащие антагонисты ccr3
JP2015502926A5 (enExample)
JP2018502824A5 (enExample)
CL2017001843A1 (es) Lixisenatida y/o una sal farmacéuticamente aceptable de la misma para el tratamiento de pacientes pediátricos con diabetes mellitus de tipo 2.
PH12017501427A1 (en) Benzoxaborole compounds and uses thereof
WO2012116196A3 (en) Substituted lactosyl compounds and use thereof for cellular imaging and therapy
JP2013513607A5 (enExample)